Acadian Asset Management
RDHL

Acadian Asset Management’s Redhill Biopharma RDHL Stock Holding History

Acadian Asset Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-918
Closed -$93K – 1879
2023
Q1 		$93K Buy
918
+258
+39% +$48.7K ﹤0.01% 1407
2022
Q4 		$92K Buy
+660
New +$286K ﹤0.01% 1454
2022
Q3 		– Sell
-31
Closed -$27K – 1812
2022
Q2 		$27K Buy
31
+14
+82% +$19.2K ﹤0.01% 1584
2022
Q1 		$42K Buy
17
+9
+113% +$21.3K ﹤0.01% 1489
2021
Q4 		$19K Buy
+8
New +$32K ﹤0.01% 1616

Other funds holding RDHL

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acadian Asset Management's RDHL Position: Q2 2023 in Review

Acadian Asset Management sold out of Redhill Biopharma (RDHL) in Q2 2023, closing a stake of 918 shares — an estimated $93K sold.

Acadian Asset Management first reported a position in RDHL in Q4 2021 and held it in 5 quarters. The position peaked at $93K in Q1 2023. 18 funds tracked by Wall St. Rank hold RDHL as of Q2 2023.

  • Acadian Asset Management reported no remaining Redhill Biopharma position as of Q2 2023 after selling out during the quarter.
  • Acadian Asset Management sold 918 Redhill Biopharma shares in Q2 2023, an estimated $93K.
  • Acadian Asset Management first reported a position in Redhill Biopharma in Q4 2021 and held it in 5 quarters.
  • Acadian Asset Management's Redhill Biopharma position peaked at $93K in Q1 2023.
  • 18 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2023.

Based on Acadian Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.